Key statistics
On Thursday, Hansa Biopharma AB (0RC7:LSE) closed at 30.03, 36.01% above the 52 week low of 22.08 set on Dec 06, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 30.85 |
---|---|
High | 30.03 |
Low | 30.03 |
Bid | 29.48 |
Offer | 30.98 |
Previous close | 30.42 |
Average volume | 1.68k |
---|---|
Shares outstanding | 67.81m |
Free float | 48.58m |
P/E (TTM) | -- |
Market cap | 2.08bn SEK |
EPS (TTM) | -11.34 SEK |
Data delayed at least 20 minutes, as of Nov 21 2024 14:37 GMT.
More ▼
Press releases
- Hansa Biopharma to Attend Truist Securities BioPharma Symposium
- Hansa Biopharma Reports Third Quarter and Interim January - September 2024 Financial Results
- Hansa Biopharma's HNSA-5487 Achieved Rapid and Highly Robust IgG Reduction by More Than 95% and Clear Redosing Potential in First-in-Human Trial
- Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference